35
Views
5
CrossRef citations to date
0
Altmetric
Articles

Cefepime Versus Ceftazidime in the Treatment of Lower Respiratory Tract Infections

Pages 213-218 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S. Sabtcheva. (1999) Susceptibility to Cefepime of Clinical Isolates of Enterobacteriaceae with Chromosomal Bush Group 1 Beta-Lactamases. Biotechnology & Biotechnological Equipment 13:2, pages 65-67.
Read now

Articles from other publishers (4)

P.N.A. Harris & J.K. Ferguson. (2012) Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?. International Journal of Antimicrobial Agents 40:4, pages 297-305.
Crossref
Dafna Yahav, Mical Paul, Abigail Fraser, Nadav Sarid & Leonard Leibovici. (2007) Efficacy and safety of cefepime: a systematic review and meta-analysis. The Lancet Infectious Diseases 7:5, pages 338-348.
Crossref
K Konstantinou, K Baddam, A Lanka, K Reddy & M Zervos. (2004) Cefepime versus Ceftazidime for Treatment of Pneumonia. Journal of International Medical Research 32:1, pages 84-93.
Crossref
JOHN S. BRADLEY & ANTONIO ARRIETA. (2001) Empiric use of cefepime in the treatment of lower respiratory tract infections in children. The Pediatric Infectious Disease Journal 20:3, pages 343-349.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.